Home 2017-02-17T13:01:24+00:00


Glu is an online community of patients and caregivers who support, empower, and educate one another while participating directly in real-time research.
T1D Exchange Clinic Network supports a large registry of adults and children with T1D for the purpose of conducting multiple studies proposed by T1D Exchange investigators, other researchers, and corporate members.
T1D Exchange Clinic Registry supports research and development projects and programs in T1D by helping researchers characterize individuals living with the disease, conduct exploratory or hypothesis-generating analyses, and identify participants for future clinical studies.
T1D Exchange Biobank centralizes thousands of biological samples—together with clinical, demographic, and study-derived information—and aims to be a world-class resource for innovative research, a catalyst for exchange of knowledge and collaboration, and addresses the unmet need of having biological samples to better understand the causes of T1D, the heterogeneity in clinical course over time, and responses to therapy.


Major Study Confirms Racial Disparities Related to Key Diabetes Indicator, Hemoglobin A1c

Standard Test for Determining Blood Sugar Control in People with Diabetes Is Not Always an Accurate Measure of Blood Sugar Control and Interpretation Differs Based on Race. Boston, MA – June 14, 2017 – [...]

T1D Exchange’s Biobank Samples Help Researchers Discover Potential Breakthrough in Understanding and Potentially Treating Diabetic Kidney Disease

Findings shed new light on potential prevention of diabetic kidney and heart disease in patients with type 1 diabetes Men with type 1 diabetes and albuminuria have greater copeptin concentrations than men with normoalbuminuria, [...]

Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring

Data from T1D Exchange Are Supportive of FDA’s Approval for New Indication for Dexcom G5® Mobile Continuous Glucose Monitoring System  Boston, MA – T1D Exchange, a nonprofit organization accelerating research to improve outcomes in type [...]


T1D Exchange Invests in Breakthrough Startup Admetsys to Improve Diabetes Care during Hospitalization

Effort Aims to Accelerate Development of the Admetsys Automated Insulin Delivery System for Hospitals and Surgical Centers BOSTON, MA, June 6, 2017 – T1D Exchange, an organization dedicated to accelerating therapies and improving care [...]

T1D Exchange Adds Strategic Leadership to Board and Team in Response to Organizational Growth

BOSTON, MA, April 11, 2016 – T1D Exchange, an organization dedicated to accelerating therapies and improving care in type 1 diabetes, today announced the election of a new Board member and the addition of [...]

REPLACE BG: A T1D Exchange Study Confirms Continuous Glucose Monitoring (CGM) Alone is as Safe and Effective as CGM with Blood Glucose Monitoring

T1D Exchange recently published the results of a major study that confirms the use of Continuous Glucose Monitoring (CGM) without regular use of confirmatory Blood Glucose Measurements (BGM) is as safe and effective as use [...]